104029-20-1

Basic information

• Product Name: ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate
• Synonyms: ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate
• CAS NO: 104029-20-1
• Molecular Weight: 256.686
• Mol File: 104029-20-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate(104029-20-1)
• EPA Substance Registry System: ethyl 3-(5-chloro-2-methoxyphenyl)-3-oxopropanoate(104029-20-1)

Safety Data

• Hazardous Substances Data: 104029-20-1(Hazardous Substances Data)

Upstream product

• 141-78-6 ethyl acetate 
• 29568-33-0 2-methoxy-5-chlorobenzoyl chloride 
• 3438-16-2 5-chloro-2-methoxybenzoic acid 
• 6342-64-9 2-methoxy-5-chloroacetophenone 
• 105-58-8 Diethyl carbonate 
• 1071-46-1 hydrogen ethyl malonate 
• 6148-64-7 ethyl potassium malonate 

Downstream Products

• 1260168-73-7 ethyl 2-(5-chloro-2-methoxybenzoyl)-3-(dimethylamino)acrylate 
• 1260168-75-9 ethyl 5-(5-chloro-2-methoxyphenyl)-1H-pyrazole-4-carboxylate 
• 1260168-77-1 ethyl 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazole-4-carboxylate 
• 1260168-79-3 ethyl 5-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazole-4-carboxylate 
• 1260168-85-1 C₁₂H₁₁ClN₂O₃ 
• 1435472-76-6 (Z)-ethyl 3-((2-amino-2-oxoethyl)amino)-3-(5-chloro-2-methoxyphenyl)acrylate 
• 1260168-88-4 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-amine 
• 1260168-87-3 tert-butyl 5-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-ylcarbamate 
• 1260168-81-7 tert-butyl 3-(5-chloro-2-methoxyphenyl)-1-methyl-1H-pyrazol-4-ylcarbamate 
• 1260168-83-9 C₁₂H₁₁ClN₂O₃ 
• 899362-89-1 ethyl 2-amino-4-(5-chloro-2-methoxyphenyl)thiazole-5-carboxylate 

Relevant articles and documents

PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

Compounds of Formula (I) and methods of use as Janus kinase inhibitors are described herein.

5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.

PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS

A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2 and R3 are defined herein, are useful as inhibitors of one or more Janus kinases. A pharmaceutical